Atorvastatin accelerates <i>Mycobacterium tuberculosis</i> clearance in pulmonary TB: a randomised phase IIA trial-Reference-Cited by-同舟云学术

Atorvastatin accelerates Mycobacterium tuberculosis clearance in pulmonary TB: a randomised phase IIA trial

Published:2023-03-01 Issue:3 Volume:27 Page:226-228
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Adewole O. O.¹,Omotoso B. A.²,Ogunsina M.³,Aminu A.⁴,Odeyemi A. O.⁵,Awopeju O. F.¹,Ayoola O.⁶,Adedeji T.⁷,Sogaolu O. M.⁸,Adewole T. O.⁹,Jiya E.¹⁰,Andero V.¹¹,Obaseki D.¹¹,Akintomide A. O.¹,Erhabor G. E.¹

Affiliation:

1. Department of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria, Department of Medicine Obafemi Awolowo University Teaching Hospitals, Ile Ife, Nigeria

2. Department of Medicine Obafemi Awolowo University Teaching Hospitals, Ile Ife, Nigeria, Clinical Pharmacology & Therapeutic Department, Obafemi Awolowo University, Ile Ife, Nigeria

3. Department of Medicine, Kaduna State University, Kaduna, Nigeria

4. Department of Medicine, Usman Fodiyo University, Sokoto, Nigeria

5. Department of Medicine, Bowen University, Iwo, Nigeria

6. Department of Radiology, Obafemi Awolowo University/Teaching Hospitals, Ile Ife, Nigeria

7. Department of Chemical Pathology, Obafemi Awolowo University/Teaching Hospitals, Ile Ife, Nigeria

8. Department of Medicine, University of Ibadan, Ibadan, Nigeria

9. Department of Family Medicine, Obafemi Awolowo University Teaching Hospitals, Ile Ife, Nigeria

10. National Tuberculosis Reference Laboratory, Zare, Kaduna, Nigeria

11. Department of Medicine Obafemi Awolowo University Teaching Hospitals, Ile Ife, Nigeria

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update to Novel Therapeutic Options for Combating Tuberculosis: Challenges and Future Prospectives;Current Pharmaceutical Biotechnology;2024-10

2. The effect of statins on the risk of anti-tuberculosis drug-induced liver injury among patients with active tuberculosis: A cohort study;Journal of Microbiology, Immunology and Infection;2024-06

3. Fluvastatin Converts Human Macrophages into Foam Cells with Increased Inflammatory Response to Inactivated Mycobacterium tuberculosis H37Ra;Cells;2024-03-18

4. Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus;Frontiers in Immunology;2024-01-08

5. Atorvastatin improves sputum conversion and chest X-ray severity score;The International Journal of Tuberculosis and Lung Disease;2023-12-01